PUS1 and neoplasm: Increasing evidences have suggested an association between abnormal expression of Ψ synthases (such as PUS1, PUS7, PUS10 and DKC1) and tumor malignant progression (Jana et al., 2017; Elsharawy et al., 2020; Du et al., 2021; Stockert et al., 2021).